Aktionärsstruktur

Inhaber in %
Freefloat 96.23
The Vanguard Group, Inc. 3.58
BlackRock Fund Advisors 3.03
Government Pension Fund - Global (The) 2.83
Norges Bank Investment Management 2.30
Schroder Investment Management Ltd. 1.73
Dodge & Cox International Stock Fund 1.65
Silchester International Investors LLP 1.63
BlackRock Advisors (UK) Ltd. 1.51
Legal & General Investment Management Ltd. 1.33
Vanguard Total International Stock Index Fund 1.30
SIX SIS Ltd. 1.26
SSgA Funds Management, Inc. 1.19
Mondrian Investment Partners Ltd. 1.16
Clearstream Banking SA 1.03

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2018 2019 2020 2021
Personal am Ende des Jahres 95'490 99'437 94'066 90'096
Umsatz pro Mitarbeiter in Mio. EUR 0.32 0.34 0.36 0.38

Bilanz (in Mio. EUR) - Aktiva

2018 2019 2020 2021
Summe Umlaufvermögen 16'927 19'491 20'247 18'674
Summe Anlagevermögen 30'424 41'913 41'737 39'228
Summe Aktiva 58'066 79'692 80'431 79'103

Bilanz (in Mio. EUR) - Passiva

2018 2019 2020 2021
Gesamtverschuldung/ -verbindlichkeiten 26'064 30'508 27'150 24'173
Summe Fremdkapital 54'394 61'335 59'623 57'761
Summe Eigenkapital 3'672 18'357 20'808 21'342
Summe Passiva 58'066 79'692 80'431 79'103

Adresse

980 Great West Road, TW8 9GS Middlesex
Telefon +44 (20) 8047-5000
Fax +44 (20) 8047-7807
URL http://gsk.com

Management

Abhishek Agrawal
Director-Strategic Account
Amy Altshul
SVP-Legal, Research & Development
Anita Kidgell
Head-Corporate Strategy
Anne C. Beal
Independent Non-Executive Director
Anne-Marie Martin
Senior VP & Global Head-Experimental Medicine Unit
Brian James McNamara
Chief Executive Officer-Consumer Healthcare
Charles A. Bancroft
Senior Independent Non-Executive Director
Christopher Corsico
Senior Vice President-Development
Claire Lund
Head-Environmental Sustainability
David Simon Redfern
Chief Strategy Officer
Deborah Jayne Waterhouse
Member-Executive Board
Diana Conrad
Chief People Officer
Dipal Patel
Head-Global Commercial
Elizabeth McKee Anderson
Non-Executive Director
Emma N. Walmsley
Chief Executive Officer & Executive Director
Hal V. Barron
Non-Independent Non-Executive Director
Harry C. Dietz
Independent Non-Executive Director
Iain James Mackay
Chief Financial Officer & Executive Director
James Ford
Group General Counsel, Head-Legal & Compliance
Jesse L. Goodman
Independent Non-Executive Director
Jon Ellis
VP & Head-Technology Business Development
Jonathan Richard Symonds
Non-Executive Chairman
Kapila Ratnam
Principal Investigator
Kevin Sin
SVP & Head-Worldwide Business Development
Luke Miels
Chief Commercial Officer
Marc Jones
Senior Vice President-Regional Pharma Supply
María Cristina de Luna Basagoiti
Chairman & General Manager-Spain
Maya Martinez-Davis
President-US Pharmaceuticals
Neil Barnes
Global Franchise Medical Head-Respiratory
Philip Thomson
President-Global Affairs
Regis Jean-Pierre Simard
President-Pharmaceutical Supply Chain
Roger Connor
President-Vaccines & Global Health
Sarah-Jane Hall
Group Treasurer & Senior Vice President
Shobie Ramakrishnan
Chief Digital & Technology Officer
Sonya Ghobrial
Head-Consumer Healthcare Investor Relations
Tony Wood
Chief Scientific Officer
Urs Rohner
Independent Non-Executive Director
Victoria A. Whyte
Secretary
Vishal Sikka
Non-Executive Director

Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen
Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.